Mazumdar Claire's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Apr 20, 2026
- Accession no.
- 0001628280-26-026089
- Filed
- Apr 20, 2026
- Trade date
- Apr 16-20, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $354.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazumdar ClaireCIK 0002034671 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | MOption exerciseAcquired | +8,226 | $4.44 | +$36,523.44 | 347,618 | Direct | |
| Apr 16, 2026 | Common Stock | MOption exerciseAcquired | +7,454 | $3.79 | +$28,250.66 | 355,072 | Direct | |
| Apr 16, 2026 | Common Stock | MOption exerciseAcquired | +7,080 | $5.45 | +$38,586 | 362,152 | Direct | |
| Apr 20, 2026 | Common Stock | MOption exerciseAcquired | +15,000 | $3.79 | +$56,850 | 377,152 | Direct | |
| Apr 20, 2026 | Common Stock | SSaleDisposed | −15,000 | $23.61 | −$354,150 | 362,152 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | MOption exerciseDisposed | −8,226 | $0.00 | $0 | 56,684 | Direct | |
| Apr 16, 2026 | Common Stock | MOption exerciseDisposed | −7,454 | $0.00 | $0 | 130,546 | Direct | |
| Apr 16, 2026 | Common Stock | MOption exerciseDisposed | −7,080 | $0.00 | $0 | 558,432 | Direct | |
| Apr 20, 2026 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 161,107 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.